Depreciation of BIOLARGO, INC. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BIOLARGO, INC. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • BIOLARGO, INC. Depreciation for the quarter ending 31 Dec 2025 was $33,000, a 21% decline year-over-year.
  • BIOLARGO, INC. Depreciation for the twelve months ending 31 Dec 2025 was $145,000, a 6.5% decline year-over-year.
  • BIOLARGO, INC. annual Depreciation for 2025 was $145,000, a 6.5% decline from 2024.
  • BIOLARGO, INC. annual Depreciation for 2024 was $155,000, a 50% increase from 2023.
  • BIOLARGO, INC. annual Depreciation for 2023 was $103,000, a 129% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

BIOLARGO, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $145,000 $33,000 -$9,000 -21% 01 Oct 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 $154,000 $34,000 -$5,000 -13% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $159,000 $36,000 -$2,000 -5.3% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $161,000 $42,000 +$6,000 +17% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $155,000 $42,000 +$33,000 +367% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 $122,000 $39,000 -$7,000 -15% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $129,000 $38,000 +$12,000 +46% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $117,000 $36,000 +$14,000 +64% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $103,000 $9,000 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $46,000 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $26,000 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $22,000 +$20,000 +1000% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $2,000 -$5,000 -71% 01 Jan 2022 31 Mar 2022 10-Q 17 May 2023 2023 Q1
Q1 2021 $7,000 -$9,000 -56% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 $16,000 $0 0% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q3 2019 $17,000 +$4,000 +31% 01 Jul 2019 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $16,000 +$3,000 +23% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $16,000 01 Jan 2019 31 Mar 2019 10-Q 19 May 2020 2020 Q1
Q3 2018 $13,000 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $13,000 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2013 $0 -$1,335 -100% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q1 2012 $1,335 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1

BIOLARGO, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $145,000 -$10,000 -6.5% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $155,000 +$52,000 +50% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $103,000 +$58,000 +129% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $45,000 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2012 $2,700 -$5,166 -66% 01 Jan 2012 31 Dec 2012 10-K 29 Mar 2013 2012 FY
2011 $7,866 01 Jan 2011 31 Dec 2011 10-K 29 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.